These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22972083)

  • 1. Terlipressin for hepatorenal syndrome.
    Gluud LL; Christensen K; Christensen E; Krag A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD005162. PubMed ID: 22972083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
    Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terlipressin for hepatorenal syndrome.
    Gluud LL; Kjaer MS; Christensen E
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005162. PubMed ID: 17054242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.
    Facciorusso A; Chandar AK; Murad MH; Prokop LJ; Muscatiello N; Kamath PS; Singh S
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):94-102. PubMed ID: 28403995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
    Best LM; Freeman SC; Sutton AJ; Cooper NJ; Tng EL; Csenar M; Hawkins N; Pavlov CS; Davidson BR; Thorburn D; Cowlin M; Milne EJ; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013103. PubMed ID: 31513287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
    Gifford FJ; Morling JR; Fallowfield JA
    Aliment Pharmacol Ther; 2017 Mar; 45(5):593-603. PubMed ID: 28052382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Int J Artif Organs; 2009 Mar; 32(3):133-40. PubMed ID: 19440988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.
    Sanyal AJ; Boyer TD; Frederick RT; Wong F; Rossaro L; Araya V; Vargas HE; Reddy KR; Pappas SC; Teuber P; Escalante S; Jamil K
    Aliment Pharmacol Ther; 2017 Jun; 45(11):1390-1402. PubMed ID: 28370090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
    Gluud LL; Christensen K; Christensen E; Krag A
    Hepatology; 2010 Feb; 51(2):576-84. PubMed ID: 19885875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
    Wang H; Liu A; Bo W; Feng X; Hu Y
    Medicine (Baltimore); 2018 Apr; 97(16):e0431. PubMed ID: 29668606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive Agents for Hepatorenal Syndrome: A Mixed Treatment Comparison Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials.
    Sridharan K; Sivaramakrishnan G
    J Gen Intern Med; 2018 Jan; 33(1):97-102. PubMed ID: 28924736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
    Nassar Junior AP; Farias AQ; D' Albuquerque LA; Carrilho FJ; Malbouisson LM
    PLoS One; 2014; 9(9):e107466. PubMed ID: 25203311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
    Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
    Fabrizi F; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(6):935-44. PubMed ID: 16948805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
    Muñoz LE; Alcalá EG; Cordero P; Martínez MA; Vázquez NY; Galindo S; Mendoza E; Segura JJ
    Ann Hepatol; 2009; 8(3):207-11. PubMed ID: 19841499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.
    Nanda A; Reddy R; Safraz H; Salameh H; Singal AK
    J Clin Gastroenterol; 2018 Apr; 52(4):360-367. PubMed ID: 28991106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis.
    Zheng JN; Han YJ; Zou TT; Zhou YJ; Sun DQ; Zhong JH; Braddock M; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1009-1018. PubMed ID: 28708431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.